Gujarat Mitul Petro -Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 24-10-2024
- Paid Up Capital ₹ 5.00 M
as on 24-10-2024
- Company Age 35 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.25 Cr
as on 24-10-2024
- Satisfied Charges ₹ 7.40 Cr
as on 24-10-2024
- Revenue 213.02%
(FY 2023)
- Profit 310.85%
(FY 2023)
- Ebitda 188.13%
(FY 2023)
- Net Worth 24.33%
(FY 2023)
- Total Assets 33.04%
(FY 2023)
About Gujarat Mitul Petro -Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹9.25 Cr. The company has closed loans amounting to ₹7.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Girish Shah and Swati Shah serve as directors at the Company.
- CIN/LLPIN
U24231GJ1989PTC012620
- Company No.
012620
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Aug 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Gujarat Mitul Petro -Pharma Private Limited offer?
Gujarat Mitul Petro -Pharma Private Limited offers a wide range of products and services, including Chemical Compound, Iodine Compounds, Sodium Iodide, Chemical Reagents & Catalysts, Potassium Salts, Potassium Iodide Powder, Insecticides and Pesticides, Pesticide Intermediate.
Who are the key members and board of directors at Gujarat Mitul Petro -Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Girish Shah  | Whole-Time Director | 14-Aug-1989 | Current |
| Swati Shah | Director | 11-Sep-2019 | Current |
Financial Performance of Gujarat Mitul Petro -Pharma.
Gujarat Mitul Petro -Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 213.02% increase. The company also saw a substantial improvement in profitability, with a 310.85% increase in profit. The company's net worth Soared by an impressive increase of 24.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gujarat Mitul Petro -Pharma?
In 2023, Gujarat Mitul Petro -Pharma had a promoter holding of 75.71% and a public holding of 24.29%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 14 Dec 2022 | ₹9.25 Cr | Open |
Bank Of Baroda Creation Date: 25 Jan 2012 | ₹1.90 Cr | Satisfied |
Bank Of Baroda Creation Date: 19 Feb 1996 | ₹2.75 Cr | Satisfied |
How Many Employees Work at Gujarat Mitul Petro -Pharma?
Unlock and access historical data on people associated with Gujarat Mitul Petro -Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gujarat Mitul Petro -Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gujarat Mitul Petro -Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
